FDA Inspection 619025 — Lonza Biologics, Inc.
The FDA completed an inspection of Lonza Biologics, Inc. on October 9, 2009 in Hopkinton, MA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- October 9, 2009
- Fiscal Year
- 2010
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Hopkinton, MA (United States)